Progress in Cancer Care – A Tsunami of Promises or Game-Changing Strategies?
Event 2020 - Speakers & Topics
Jason J. Luke, MD, FACP, Director of the Cancer Immunotherapeutics Center, Associate Professor of Medicine, University of Pittsburgh Medical Center and Hillman Cancer Center, USA
The Tumor Microenvironment and the Microbiome and their Impact on Cancer Immunotherapy – What do we Know, Where are the Gaps, and Where are we Heading?
Stefani Spranger, Howard S. and Linda B. Stern Career Development Assistant Professor, Koch Institute for Integrative Cancer Research at MIT, Cambridge, USA
Understanding the Co-evolution of the Anti-tumor Immune Response and Cancer
Harriet Wikman, Professor, Group Leader, Center for Experimental Medicine, Institute of Tumor Biology, University Medical Centre Hamburg-Eppendorf, Germany
Recent Progress and Clinical Implementation in the Liquid Biopsy Field
Vessela Kristensen, Professor, Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway Peter A. Fasching, Professor of Translational Gynecology and Obstetrics, University Hospital and Comprehensive Cancer Center Erlangen-EMN, Germany
Cancer Genome Variation and Clinical Implications
Michel Sadelain, Professor, Director, Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, USA Hermann Einsele, Professor, Chair, Dept. of Internal Medicine II, Head of the Clinical and Translational Research Program on Multiple Myeloma, University Hospital Wuerzburg, Germany
Novel Strategies and Better Patient Management – The Way Forward for Treating Multiple Myeloma
Evening Keynote Speaker: Ole Petter Ottersen, Professor, President Karolinska Institute, Stockholm, Sweden